Grunenthal | Sustainability Performance
Specializes in research and development of pain management and related pharmaceutical products.
1949
Germany
1,001 - 5,000 employees
Pharmaceuticals
$1B - 10B in revenue
Sustainability Ranking & Industry Benchmark
#6167
Overall#297
in Germany#128
in PharmaceuticalsSustainability Maturity
Sustainability Intent
Overview
Controversy level
- Grünenthal's predecessor company manufactured thalidomide, causing severe birth defects worldwide.
